FDA Inspection 820917 — Frontida Biopharm, LLC
The FDA completed an inspection of Frontida Biopharm, LLC on February 26, 2013 in Aurora, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 26, 2013
- Fiscal Year
- 2013
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Aurora, IL (United States)